195 related articles for article (PubMed ID: 8452127)
21. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
23. Use of Medicare data to identify incident breast cancer cases.
Warren JL; Riley GF; McBean AM; Hakim R
Health Care Financ Rev; 1996; 18(1):237-46. PubMed ID: 10165033
[TBL] [Abstract][Full Text] [Related]
24. Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?
Ballard DJ; Bryant SC; O'Brien PC; Smith DW; Pine MB; Cortese DA
Health Serv Res; 1994 Feb; 28(6):771-84. PubMed ID: 8113057
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the HCFA model for the analysis of mortality following hospitalization.
Krakauer H; Bailey RC; Skellan KJ; Stewart JD; Hartz AJ; Kuhn EM; Rimm AA
Health Serv Res; 1992 Aug; 27(3):317-35. PubMed ID: 1500289
[TBL] [Abstract][Full Text] [Related]
26. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
[TBL] [Abstract][Full Text] [Related]
27. Use of Medicare hospital and physician data to assess breast cancer incidence.
Warren JL; Feuer E; Potosky AL; Riley GF; Lynch CF
Med Care; 1999 May; 37(5):445-56. PubMed ID: 10335747
[TBL] [Abstract][Full Text] [Related]
28. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
[TBL] [Abstract][Full Text] [Related]
29. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
[TBL] [Abstract][Full Text] [Related]
30. Use of Medicare claims data to measure county-level variations in the incidence of colorectal carcinoma.
Cooper GS; Yuan Z; Stange KC; Rimm AA
Cancer; 1998 Aug; 83(4):673-8. PubMed ID: 9708930
[TBL] [Abstract][Full Text] [Related]
31. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
32. Surveillance for Cancer Incidence and Mortality - United States, 2013.
Singh SD; Henley SJ; Ryerson AB
MMWR Surveill Summ; 2017 Jan; 66(4):1-36. PubMed ID: 28125567
[TBL] [Abstract][Full Text] [Related]
33. New Opportunities for Cancer Health Services Research: Linking the SEER-Medicare Data to the Nursing Home Minimum Data Set.
Thomas KS; Boyd E; Mariotto AB; Penn DC; Barrett MJ; Warren JL
Med Care; 2018 Dec; 56(12):e90-e96. PubMed ID: 29401187
[TBL] [Abstract][Full Text] [Related]
34. Aggressiveness of intensive care use among patients with lung cancer in the Surveillance, Epidemiology, and End Results-Medicare registry.
Cooke CR; Feemster LC; Wiener RS; O'Neil ME; Slatore CG
Chest; 2014 Oct; 146(4):916-923. PubMed ID: 25117058
[TBL] [Abstract][Full Text] [Related]
35. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
36. Future of cancer incidence in the United States: burdens upon an aging, changing nation.
Smith BD; Smith GL; Hurria A; Hortobagyi GN; Buchholz TA
J Clin Oncol; 2009 Jun; 27(17):2758-65. PubMed ID: 19403886
[TBL] [Abstract][Full Text] [Related]
37. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
[TBL] [Abstract][Full Text] [Related]
38. Determinants of NCI Cancer Center attendance in Medicare patients with lung, breast, colorectal, or prostate cancer.
Onega T; Duell EJ; Shi X; Demidenko E; Goodman D
J Gen Intern Med; 2009 Feb; 24(2):205-10. PubMed ID: 19067086
[TBL] [Abstract][Full Text] [Related]
39. Patterns and predictors of home health and hospice use by older adults with cancer.
Locher JL; Kilgore ML; Morrisey MA; Ritchie CS
J Am Geriatr Soc; 2006 Aug; 54(8):1206-11. PubMed ID: 16913986
[TBL] [Abstract][Full Text] [Related]
40. Hospitalization of hospice patients with cancer.
Cintron A; Hamel MB; Davis RB; Burns RB; Phillips RS; McCarthy EP
J Palliat Med; 2003 Oct; 6(5):757-68. PubMed ID: 14622455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
